While Guardant Health Inc has underperformed by -0.58%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GH rose by 56.50%, with highs and lows ranging from $53.42 to $20.14, whereas the simple moving average jumped by 22.96% in the last 200 days.
On April 10, 2025, Mizuho started tracking Guardant Health Inc (NASDAQ: GH) recommending Outperform. A report published by Barclays on January 23, 2025, Initiated its previous ‘Overweight’ rating for GH. Guggenheim also Upgraded GH shares as ‘Buy’, setting a target price of $36 on the company’s shares in a report dated June 28, 2024. Jefferies Initiated an Buy rating on June 03, 2024, and assigned a price target of $32. Craig Hallum initiated its ‘Buy’ rating for GH, as published in its report on April 24, 2024. Wolfe Research also rated the stock as ‘Peer Perform’.
Analysis of Guardant Health Inc (GH)
Further, the quarter-over-quarter increase in sales is 20.76%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Guardant Health Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -4584.47% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.76, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and GH is recording an average volume of 2.24M. On a monthly basis, the volatility of the stock is set at 4.15%, whereas on a weekly basis, it is put at 3.64%, with a loss of -6.33% over the past seven days. Furthermore, long-term investors anticipate a median target price of $59.00, showing growth from the present price of $47.81, which can serve as yet another indication of whether GH is worth investing in or should be passed over.
How Do You Analyze Guardant Health Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 4.95%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 96.53% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
GH shares are owned by institutional investors to the tune of 96.53% at present.
